Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy; Centre for Chronic Intestinal Failure, IRCCS AOUBO, Bologna, Italy.
Centre for Chronic Intestinal Failure, IRCCS AOUBO, Bologna, Italy.
Clin Nutr ESPEN. 2024 Oct;63:736-747. doi: 10.1016/j.clnesp.2024.07.022. Epub 2024 Jul 27.
To investigate the association between malnutrition and patient outcome following hospitalisation for Corona Virus Disease 2019 (COVID-19).
In April 2020, 268 adult patients (235 included in the follow-up) hospitalised for COVID-19 infection were evaluated for malnutrition risk and diagnosis using modified Nutritional Risk Screening 2002 and modified Global Leadership Initiative on Malnutrition criteria (GLIM), respectively. An 18-month follow-up was carried out to assess the incidence and the associated risk factors for death and re-hospitalization.
The outcome was unknown for 33 patients. Death occurred in 39% of the 235 patients included in the follow-up. The risk of death was independently associated with malnutrition risk or diagnosis of malnutrition, whereas the male sex showed a protective association. The Kaplan-Meier survival curves showed that patients with diagnosis of malnutrition had lower survival rate. The re-hospitalization rate was 31% and was negatively associated with BMI≥25, and positively associated with length of hospitalisation for COVID-19 and with cancer comorbidity.
In hospitalized patients for SARS-CoV-2 disease, both malnutrition risk (p = 0.050) and diagnosis of malnutrition (p = 0.047 with modified GLIM and C-reactive protein >0.5 mg/dL; p = 0.024 with modified GLIM and C-reactive protein >5 mg/dL) were predictive risk factors for mortality, whereas male sex was associated with lower risk of death. Overweight at time of hospitalization and the length of hospitalisation were respectively protective and risk factor for re-hospitalization after discharge.
研究 COVID-19 住院患者营养不良与患者结局的相关性。
2020 年 4 月,对 268 例成人 COVID-19 感染住院患者进行营养不良风险和诊断评估,分别采用改良 2002 年营养风险筛查和改良全球领导力倡议下的营养不良(GLIM)标准。进行了 18 个月的随访,以评估死亡和再住院的发生率及相关危险因素。
33 例患者的结局未知。235 例随访患者中 39%死亡。死亡的风险与营养不良风险或营养不良的诊断独立相关,而男性则表现出保护作用。Kaplan-Meier 生存曲线显示,营养不良诊断患者的生存率较低。再住院率为 31%,与 BMI≥25 呈负相关,与 COVID-19 住院时间和癌症合并症呈正相关。
在 SARS-CoV-2 疾病住院患者中,营养不良风险(p=0.050)和营养不良诊断(p=0.047 时采用改良 GLIM 标准和 C 反应蛋白>0.5mg/dL;p=0.024 时采用改良 GLIM 标准和 C 反应蛋白>5mg/dL)是死亡的预测危险因素,而男性则与较低的死亡风险相关。住院时超重和住院时间分别是出院后再住院的保护因素和危险因素。